(NASDAQ: SHC) Sotera Health Co's forecast annual revenue growth rate of 5.75% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 8.47%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 14.13%.
Sotera Health Co's revenue in 2026 is $1,189,139,000.On average, 12 Wall Street analysts forecast SHC's revenue for 2026 to be $356,743,909,494, with the lowest SHC revenue forecast at $343,911,394,764, and the highest SHC revenue forecast at $372,142,927,170. On average, 12 Wall Street analysts forecast SHC's revenue for 2027 to be $378,131,434,044, with the lowest SHC revenue forecast at $363,587,917,350, and the highest SHC revenue forecast at $396,382,121,660.
In 2028, SHC is forecast to generate $401,515,127,552 in revenue, with the lowest revenue forecast at $385,830,942,882 and the highest revenue forecast at $420,906,483,144.